Spectra7 Microsystems Inc. (SEV.V)
| Previous Close | 0.1150 |
| Open | 0.1200 |
| Bid | 0.1150 x 0 |
| Ask | 0.1400 x 0 |
| Day's Range | 0.1150 - 0.1200 |
| 52 Week Range | 0.0800 - 0.8800 |
| Volume | |
| Avg. Volume | 14,236 |
| Market Cap | 16.381M |
| Beta (5Y Monthly) | 2.72 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4700 |
| Earnings Date | Aug 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CNW GroupSpectra7 Announces Financial Results for Second Quarter 2024
(TSXV:SEV) (OTCQB:SPVNF) Spectra7 Microsystems Inc. ("Spectra7" or the "Company"), a leader in high-performance analog semiconductors for broadband connectivity markets, such as AI networks, hyperscale data centers, and AR/VR, today announced its financial results for the three and six months ended June 30, 2024. A copy of the unaudited interim consolidated financial statements for the three and six months ended June 30, 2024, and the corresponding management's discussion and analysis (the "MD&A
- CNW Group
Spectra7 Announces Results of its 2024 Annual and Special Meeting of Shareholders
(TSXV:SEV) (OTCQB:SPVNF) Spectra7 Microsystems Inc. ("Spectra7" or the "Company"), a leader in high-performance analog semiconductors for broadband connectivity markets, such as AI networks, hyperscale data centers, and AR/VR, today announced the results of its annual and special meeting of shareholders that was held on June 27, 2024.
- CNW Group
Spectra7 Announces Retirement of CEO Raouf Halim; Board Chair Ron Pasek to Assume Role on Interim Basis
(TSXV: SEV) (OTCQB: SPVNF) Spectra7 Microsystems Inc. ("Spectra7" or the "Company"), a leader in high-performance analog semiconductors for broadband connectivity markets, such as AI networks, hyperscale data centers, and AR/VR, today announced that Raouf Halim, Chief Executive Officer, has retired effective June 15, 2024. Ron Pasek, current Chair of the Board of Directors, has been appointed as Interim CEO while the Board conducts a comprehensive search for a permanent successor.
